Physician profile
Timothy P Fox
NPI 1568805471
$1,454.58
in general payments reported to CMS, 2019-2025
8 companies · $97.10 in 2025
The $97.10 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2021: $65.04 · 2022: $526 · 2023: $280 · 2024: $31.97 · 2025: $97.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $426.51 | 2022-2023 | Omni Surgical System |
| Allergan, INC. | $349.52 | 2019-2022 | |
| Alcon Vision LLC | $255.37 | 2019-2025 | Hydrus Microstent, Centurion, Clareon |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $249.85 | 2019 | |
| Abbvie INC. | $88.59 | 2022 | |
| Glaukos Corporation | $35.72 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $27.50 | 2025 | Iolmaster 700 |
| Nova Eye, INC. | $21.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.